Versions Compared

Old Version 16

changes.mady.by.user Jordan Li

Saved on

compared with

New Version 17

changes.mady.by.user Jordan Li

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

  1. There is a need to model whether or not a non-tumor lesion is identified in a region.
    1. This requires imaging location to be modeled in the TU domain.
    2. TU modeling needs to allow the creation of a “negative” record – I looked at this location but didn’t find what I suspected.
  2. Once a non-tumor lesion is identified, it may not always undergo “assessment of disease response to therapy (i.e. RS)”, it may be further classified based on severity, anatomy or other types of classifications based on a published, validated public domain or copyrighted criteria. In this case, this should be modeled in the CC portion of the RS/CC combined domain.
  3. Results in TU are typically in the form of Target/Non-target, this is used to assign an identified tumor for subsequent assessment of disease response to treatment. This doesn't always happen for non-tumor lesion. To get around this issue: for the "where is it?" question for non-tumor lesions, suggesting a different TUTEST = XXX Location Identification, where TUORRES = Located.

...